Perrigo Co PLC (PRGO)
41.17
+0.79 +1.96%
NYSE
Apr 15, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 5.063B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.20 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -162.60M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 36.39% |
| Profit Margin (Quarterly) | -13.57% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 2.22% |
| Price and Valuation | |
| Market Cap | 5.499B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 1.112 |
| PE Ratio | -- |
| Price to Book Value | 0.9724 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.6306 |
| Free Cash Flow (Quarterly) | 44.30M |
| Return on Equity | Upgrade |
View All PRGO News
News
-
WireHeadlineTime (ET)
-
Yahoo04/14 15:54
-
Yahoo03/28 11:42
-
Yahoo03/25 16:49
-
Yahoo03/10 10:14
-
MT Newswires03/05 10:52
-
Yahoo03/04 02:34
-
MT Newswires03/02 08:35
-
Yahoo03/01 13:00
-
Yahoo03/01 12:45
-
SA Breaking News03/01 11:10
-
Yahoo03/01 10:33
-
MT Newswires03/01 10:19
-
MT Newswires03/01 09:35
-
MT Newswires03/01 09:09
-
MT Newswires03/01 08:38
-
Yahoo03/01 08:25
-
Yahoo03/01 08:08
-
MT Newswires03/01 08:07
-
Yahoo03/01 07:46
-
SA Breaking News03/01 07:45
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 04/30/2020 08:30 EDT | Earnings Calls | Q1 2020 Earnings Call |
| 04/30/2020 00:00 | Earnings Results | Q1 2020 Earnings Results |
| 05/06/2020 11:30 IST | Agm | 2019 Annual General Meeting |
| 05/28/2020 None | Dividends | 0.225 Normal, declared May 05, 2020 and paid June 16, 2020 |
| 08/05/2020 09:00 EDT | Earnings Calls | Q2 2020 Earnings Call |
| 08/05/2020 00:00 | Earnings Results | Q2 2020 Earnings Results |
| 08/27/2020 None | Dividends | 0.225 Normal, declared July 29, 2020 and paid September 15, 2020 |
| 11/04/2020 00:00 | Earnings Results | Q3 2020 Earnings Results |
| 11/04/2020 16:30 EST | Earnings Calls | Q3 2020 Earnings Call |
| 11/25/2020 None | Dividends | 0.225 Normal, declared October 22, 2020 and paid December 15, 2020 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: Perrigo is the leading provider of over-the-counter generic drugs with over 100 global locations. The company was formed in 1887 as a packager of home remedies and has grown with the migration of prescriptions switching to OTC and later with strategic acquisitions. The company has a portfolio of more than 3,000 product formulations and 14,000 stock-keeping units. Most of its manufacturing and customer base reside in North America. With the most recent management change, the company announced a narrower focus on consumer wellness in conjunction with the divestiture of animal health, acquisition of Ranir Global Holdings, and plans to sell or spin off the prescription business.
- URL: https://www.perrigo.com
- Investor Relations URL: http://perrigo.investorroom.com/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Equity Style: Small Cap/Value
- Next Earnings Release: Apr. 30, 2021
- Last Earnings Release: Mar. 01, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Mar. 11, 2021
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 41.17 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| XPH | SPDR® S&P Pharmaceuticals ETF | 4.29% |
| SLVCX | Saratoga Large Capitalization Value C | 3.40% |
| PILL | Direxion Daily Phrmctcl&MdclBl3XShrsETF | 3.10% |
| PJP | Invesco Dynamic Pharmaceuticals ETF | 3.00% |
| SSHVX | Sound Shore Institutional | 2.94% |
| CSINX | Centerstone International C | 2.50% |
| TMPRX | Touchstone Mid Cap R6 | 2.37% |
| CBMCX | Wells Fargo C&B Mid Cap Value C | 2.07% |
| IHE | iShares US Pharmaceuticals ETF | 2.03% |
| MFCCX | Meridian Contrarian C | 2.01% |
| PPH | VanEck Vectors Pharmaceutical ETF | 1.44% |
| GRX | Gabelli Health & Wellness | 1.39% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- PRGO Tweets Stocktwits
Advertisement
